TY - JOUR
T1 - T-cell exhaustion signatures vary with tumor type and are severe in glioblastoma
AU - Woroniecka, Karolina
AU - Chongsathidkiet, Pakawat
AU - Rhodin, Kristen
AU - Kemeny, Hanna
AU - Dechant, Cosette
AU - Harrison Farber, S.
AU - Elsamadicy, Aladine A.
AU - Cui, Xiuyu
AU - Koyama, Shohei
AU - Jackson, Christina
AU - Hansen, Landon J.
AU - Johanns, Tanner M.
AU - Sanchez-Perez, Luis
AU - Chandramohan, Vidyalakshmi
AU - Yu, Yen Rei Andrea
AU - Bigner, Darell D.
AU - Giles, Amber
AU - Healy, Patrick
AU - Dranoff, Glenn
AU - Weinhold, Kent J.
AU - Dunn, Gavin P.
AU - Fecci, Peter E.
N1 - Publisher Copyright:
© 2018 American Association for Cancer Research.
PY - 2018/9/1
Y1 - 2018/9/1
N2 - Purpose: T-cell dysfunction is a hallmark of glioblastoma (GBM). Although anergy and tolerance have been well characterized, T-cell exhaustion remains relatively unexplored. Exhaustion, characterized in part by the upregulation of multiple immune checkpoints, is a known contributor to failures amid immune checkpoint blockade, a strategy that has lacked success thus far in GBM. This study is among the first to examine, and credential as bona fide, exhaustion among T cells infiltrating human and murine GBM. Experimental Design: Tumor-infiltrating and peripheral blood lymphocytes (TILs and PBLs) were isolated from patients with GBM. Levels of exhaustion-associated inhibitory receptors and poststimulation levels of the cytokines IFNg, TNFa, and IL2 were assessed by flow cytometry. T-cell receptor Vb chain expansion was also assessed in TILs and PBLs. Similar analysis was extended to TILs isolated from intracranial and subcutaneous immunocom-petent murine models of glioma, breast, lung, and melanoma cancers. Results: Our data reveal that GBM elicits a particularly severe T-cell exhaustion signature among infiltrating T cells characterized by: (1) prominent upregulation of multiple immune checkpoints; (2) stereotyped T-cell transcriptional programs matching classical virus-induced exhaustion; and (3) notable T-cell hyporesponsiveness in tumor-specific T cells. Exhaustion signatures differ predictably with tumor identity, but remain stable across manipulated tumor locations. Conclusions: Distinct cancers possess similarly distinct mechanisms for exhausting T cells. The poor TIL function and severe exhaustion observed in GBM highlight the need to better understand this tumor-imposed mode of T-cell dysfunction in order to formulate effective immunotherapeutic strategies targeting GBM.
AB - Purpose: T-cell dysfunction is a hallmark of glioblastoma (GBM). Although anergy and tolerance have been well characterized, T-cell exhaustion remains relatively unexplored. Exhaustion, characterized in part by the upregulation of multiple immune checkpoints, is a known contributor to failures amid immune checkpoint blockade, a strategy that has lacked success thus far in GBM. This study is among the first to examine, and credential as bona fide, exhaustion among T cells infiltrating human and murine GBM. Experimental Design: Tumor-infiltrating and peripheral blood lymphocytes (TILs and PBLs) were isolated from patients with GBM. Levels of exhaustion-associated inhibitory receptors and poststimulation levels of the cytokines IFNg, TNFa, and IL2 were assessed by flow cytometry. T-cell receptor Vb chain expansion was also assessed in TILs and PBLs. Similar analysis was extended to TILs isolated from intracranial and subcutaneous immunocom-petent murine models of glioma, breast, lung, and melanoma cancers. Results: Our data reveal that GBM elicits a particularly severe T-cell exhaustion signature among infiltrating T cells characterized by: (1) prominent upregulation of multiple immune checkpoints; (2) stereotyped T-cell transcriptional programs matching classical virus-induced exhaustion; and (3) notable T-cell hyporesponsiveness in tumor-specific T cells. Exhaustion signatures differ predictably with tumor identity, but remain stable across manipulated tumor locations. Conclusions: Distinct cancers possess similarly distinct mechanisms for exhausting T cells. The poor TIL function and severe exhaustion observed in GBM highlight the need to better understand this tumor-imposed mode of T-cell dysfunction in order to formulate effective immunotherapeutic strategies targeting GBM.
UR - http://www.scopus.com/inward/record.url?scp=85050928290&partnerID=8YFLogxK
U2 - 10.1158/1078-0432.CCR-17-1846
DO - 10.1158/1078-0432.CCR-17-1846
M3 - Article
C2 - 29437767
AN - SCOPUS:85050928290
SN - 1078-0432
VL - 24
SP - 4175
EP - 4186
JO - Clinical Cancer Research
JF - Clinical Cancer Research
IS - 17
ER -